{"id":8963,"date":"2026-04-07T07:28:13","date_gmt":"2026-04-07T07:28:13","guid":{"rendered":"https:\/\/farmalider.com\/?p=8963"},"modified":"2026-04-08T06:33:41","modified_gmt":"2026-04-08T06:33:41","slug":"the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston","status":"publish","type":"post","link":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/","title":{"rendered":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"8963\" class=\"elementor elementor-8963\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-180352a5 e-flex e-con-boxed e-con e-parent\" data-id=\"180352a5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2d5f4957 elementor-widget elementor-widget-text-editor\" data-id=\"2d5f4957\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"106\" data-end=\"223\"><\/p>\n<p class=\"wp-block-paragraph\">Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Mara\u00f1\u00f3n Health Research Institute (Madrid, Spain), has participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026, which has just concluded in Boston.<\/p>\n<p data-start=\"106\" data-end=\"223\"> <\/p>\n<p class=\"wp-block-paragraph\">He delivered the presentation <em>\u201cUncovering Clinical Advances with thyTregs\u2122 to Expand the Frontiers of Treg Therapy,\u201d<\/em> selected by the conference organizers as one of its featured sessions.<\/p>\n<p data-start=\"106\" data-end=\"223\"> <\/p>\n<p class=\"wp-block-paragraph\">Specifically, the company presented its clinical experience with thyTregs\u2122, a cell therapy derived from thymic tissue, highlighting the favorable results achieved in pediatric heart transplant patients, as well as its ongoing development as an allogeneic therapy, which will enable expansion into other immune-mediated indications. The session addressed the clinical advances of thyTregs\u2122, its therapeutic potential, and its scalability for future applications.<\/p>\n<p data-start=\"106\" data-end=\"223\"> <\/p>\n<p class=\"wp-block-paragraph\">Dr. Correa-Rocha was accompanied by researchers Esther Bernaldo de Quir\u00f3s Plaza and Marta Mart\u00ednez-Bonet, co-founders of ThyTech, as well as Mar\u00eda Luisa Berenguer Mu\u00f1oz, CEO of Farmalider and ideaTx, and Jos\u00e9 \u00c1ngel S\u00e1nchez-Garc\u00eda, Biotech Innovation Director at the Farmalider ideaTx Group, an investor and industrial partner in the development of ThyTech. This collaboration is aimed at supporting the company\u2019s growth and enabling its future scalability from executive, regulatory, technical, and industrial perspectives.<\/p>\n<p data-start=\"106\" data-end=\"223\"><\/p>\n<p><!-- \/wp:paragraph --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a4b8fb5 elementor-widget elementor-widget-image\" data-id=\"a4b8fb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"900\" height=\"1600\" src=\"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01.png\" class=\"attachment-full size-full wp-image-8966\" alt=\"\" srcset=\"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01.png 900w, https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01-169x300.png 169w, https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01-576x1024.png 576w, https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01-768x1365.png 768w, https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/phma01-864x1536.png 864w\" sizes=\"(max-width: 900px) 100vw, 900px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bae3c9c elementor-widget elementor-widget-text-editor\" data-id=\"bae3c9c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><!-- wp:paragraph {\"align\":\"left\"} --><\/p>\n<p class=\"has-text-align-left\">This international congress brought together biopharma companies, academic institutions, and experts in clinical development, manufacturing, regulation, and investment in Treg therapies. Among the most prominent organizations participating in the event were AstraZeneca, the NIH, Harvard Medical School, Johns Hopkins University, Nektar Therapeutics, and Quell Therapeutics.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p><strong>Innovative therapy<\/strong><\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>ThyTech\u2019s thyTreg\u00ae technology, fully developed at the Gregorio Mara\u00f1\u00f3n Hospital, is based on the therapeutic use of pediatric thymus tissue\u2014typically discarded during certain pediatric cardiac surgeries\u2014to obtain Treg cells with a very high potential to induce immune tolerance. This approach aims to prevent or reduce transplant rejection, autoimmune diseases, and other inflammatory conditions.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>In the field of transplantation, one of the main clinical challenges remains the need for lifelong chronic immunosuppressive treatments, which carry a significant burden for patients. In this context, ThyTech\u2019s thyTregs\u2122 approach seeks to move toward a more precise alternative for preventing rejection and, in the future, to help reduce dependence on these treatments, ultimately improving the quality of life of transplant patients.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p><strong>International recognition<\/strong><\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>ThyTech\u2019s participation in Boston comes at a particularly significant moment for the Treg field. The 2025 Nobel Prize in Medicine awarded to Shimon Sakaguchi, Mary Brunkow, and Fred Ramsdell has reinforced the international visibility and scientific validation of this therapeutic approach.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>The inclusion of the thyTreg clinical trial and the citation of Dr. Correa-Rocha\u2019s work in publications supported by Nobel laureate Fred Ramsdell further establish ThyTech as an international reference in the clinical application of Treg therapies and as a high-value asset capable of attracting the interest of the pharmaceutical industry and the global scientific community.<\/p>\n<p><!-- \/wp:paragraph --> <!-- wp:paragraph --><\/p>\n<p>More info: <a href=\"https:\/\/www.phmk.es\/tecnologia\/el-proyecto-espanol-thytech-se-presenta-en-el-8-treg-directed-therapies-summit-2026-de-boston\">Pharma Market<\/a><\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p data-start=\"106\" data-end=\"223\"><!-- \/wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Mara\u00f1\u00f3n Health Research Institute (Madrid, Spain), has participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026, which has just concluded in Boston. He delivered the presentation \u201cUncovering Clinical Advances with thyTregs\u2122 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":8974,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[45,44],"class_list":["post-8963","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-certificate","tag-ciege"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider\" \/>\n<meta property=\"og:description\" content=\"Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Mara\u00f1\u00f3n Health Research Institute (Madrid, Spain), has participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026, which has just concluded in Boston. He delivered the presentation \u201cUncovering Clinical Advances with thyTregs\u2122 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"Farmalider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61560873497178\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T07:28:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-08T06:33:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Farmalider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Farmalider\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/\"},\"author\":{\"name\":\"Farmalider\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#\\\/schema\\\/person\\\/1e36eac4bc7c00ea1f65cdcf3c41783a\"},\"headline\":\"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston\",\"datePublished\":\"2026-04-07T07:28:13+00:00\",\"dateModified\":\"2026-04-08T06:33:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/\"},\"wordCount\":498,\"publisher\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaMarket.jpg\",\"keywords\":[\"Certificate\",\"CIEGE\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/\",\"url\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/\",\"name\":\"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaMarket.jpg\",\"datePublished\":\"2026-04-07T07:28:13+00:00\",\"dateModified\":\"2026-04-08T06:33:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#primaryimage\",\"url\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaMarket.jpg\",\"contentUrl\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaMarket.jpg\",\"width\":2500,\"height\":1500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/farmalider.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/farmalider.com\\\/es\\\/\",\"name\":\"Farmal\u00edder\",\"description\":\"Driving Innovation in Health\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/farmalider.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#organization\",\"name\":\"Farmal\u00edder\",\"url\":\"https:\\\/\\\/farmalider.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/logo-farmalider.png\",\"contentUrl\":\"https:\\\/\\\/farmalider.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/logo-farmalider.png\",\"width\":1500,\"height\":190,\"caption\":\"Farmal\u00edder\"},\"image\":{\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61560873497178\",\"https:\\\/\\\/www.instagram.com\\\/farmalidergroup\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/farmalider\\\/about\\\/?viewAsMember=true\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmalider.com\\\/es\\\/#\\\/schema\\\/person\\\/1e36eac4bc7c00ea1f65cdcf3c41783a\",\"name\":\"Farmalider\",\"url\":\"https:\\\/\\\/farmalider.com\\\/es\\\/author\\\/aitor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/","og_locale":"es_ES","og_type":"article","og_title":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider","og_description":"Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Mara\u00f1\u00f3n Health Research Institute (Madrid, Spain), has participated for the second consecutive year as an invited speaker at the 8th Treg-Directed Therapies Summit 2026, which has just concluded in Boston. He delivered the presentation \u201cUncovering Clinical Advances with thyTregs\u2122 [&hellip;]","og_url":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/","og_site_name":"Farmalider","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61560873497178","article_published_time":"2026-04-07T07:28:13+00:00","article_modified_time":"2026-04-08T06:33:41+00:00","og_image":[{"width":2500,"height":1500,"url":"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg","type":"image\/jpeg"}],"author":"Farmalider","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Farmalider","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#article","isPartOf":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/"},"author":{"name":"Farmalider","@id":"https:\/\/farmalider.com\/es\/#\/schema\/person\/1e36eac4bc7c00ea1f65cdcf3c41783a"},"headline":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston","datePublished":"2026-04-07T07:28:13+00:00","dateModified":"2026-04-08T06:33:41+00:00","mainEntityOfPage":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/"},"wordCount":498,"publisher":{"@id":"https:\/\/farmalider.com\/es\/#organization"},"image":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg","keywords":["Certificate","CIEGE"],"articleSection":["Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/","url":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/","name":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston - Farmalider","isPartOf":{"@id":"https:\/\/farmalider.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#primaryimage"},"image":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg","datePublished":"2026-04-07T07:28:13+00:00","dateModified":"2026-04-08T06:33:41+00:00","breadcrumb":{"@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#primaryimage","url":"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg","contentUrl":"https:\/\/farmalider.com\/wp-content\/uploads\/2026\/04\/pharmaMarket.jpg","width":2500,"height":1500},{"@type":"BreadcrumbList","@id":"https:\/\/farmalider.com\/es\/the-spanish-project-thytech-is-presented-at-the-8th-treg-directed-therapies-summit-2026-in-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/farmalider.com\/"},{"@type":"ListItem","position":2,"name":"The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston"}]},{"@type":"WebSite","@id":"https:\/\/farmalider.com\/es\/#website","url":"https:\/\/farmalider.com\/es\/","name":"Farmal\u00edder","description":"Driving Innovation in Health","publisher":{"@id":"https:\/\/farmalider.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/farmalider.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/farmalider.com\/es\/#organization","name":"Farmal\u00edder","url":"https:\/\/farmalider.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/farmalider.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/farmalider.com\/wp-content\/uploads\/2024\/09\/logo-farmalider.png","contentUrl":"https:\/\/farmalider.com\/wp-content\/uploads\/2024\/09\/logo-farmalider.png","width":1500,"height":190,"caption":"Farmal\u00edder"},"image":{"@id":"https:\/\/farmalider.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61560873497178","https:\/\/www.instagram.com\/farmalidergroup\/","https:\/\/www.linkedin.com\/company\/farmalider\/about\/?viewAsMember=true"]},{"@type":"Person","@id":"https:\/\/farmalider.com\/es\/#\/schema\/person\/1e36eac4bc7c00ea1f65cdcf3c41783a","name":"Farmalider","url":"https:\/\/farmalider.com\/es\/author\/aitor\/"}]}},"_links":{"self":[{"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/posts\/8963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/comments?post=8963"}],"version-history":[{"count":5,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/posts\/8963\/revisions"}],"predecessor-version":[{"id":8975,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/posts\/8963\/revisions\/8975"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/media\/8974"}],"wp:attachment":[{"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/media?parent=8963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/categories?post=8963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmalider.com\/es\/wp-json\/wp\/v2\/tags?post=8963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}